Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome
The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Abstract
Objective: Polycystic ovary syndrome (PCOS) is associated with insulin resistance and obesity. Prospective population-based data regarding development and possible predictors of type 2 diabetes (T2D) in PCOS are limited. Design: National Patient Register-based study. Methods: Patients with PCOS [PCOS Denmark and embedded cohort, PCOS Odense University Hospital (OUH)] and a control population with no previous diagnosis of T2D. PCOS OUH (N = 1,162) included premenopausal women with PCOS and standardized clinical and biochemical examination. PCOS Denmark (N = 18,477) included women with PCOS in the Danish National Patient Register. Three age-matched controls were included per patient (N = 54,680). Main outcome: T2D events according to diagnosis codes and filled medicine prescriptions. Results: The median (quartiles) follow-up was 11.1 (6.9 to 16.0) years. The hazard ratio (HR) with 95% confidence interval (CI) for development of T2D in PCOS Denmark was HR = 4.0 (95% CI, 3.7 to 4.3; P < 0.001), and the total event rate of T2D was 8.0 per 1000 person years in PCOS Denmark vs 2.0 per 1000 person years in controls (P < 0.001). The median age at diagnosis of T2D was 31 (26 to 37) years in PCOS Denmark vs 35 (27 to 44) years in controls (P < 0.001). In multiple regression analyses, body mass index, glycated hemoglobin, fasting blood glucose, 2-hour blood glucose, homeostasis model assessment of insulin resistance, and triglycerides were positively associated with development of T2D, whereas higher number of births was negatively associated with development of T2D. Conclusion: The event rate of T2D was higher in PCOS compared with controls, and T2D was diagnosed at a younger age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PCOS is associated with increased co-morbidities including obesity, infertility, pregnancy complications, depression and anxiety, metabolic syndrome, diabetes, reproductive cancers and cardiovascular disease [3, 7, 8, 10–13].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [10]
In the citing paper
“PCOS is associated with a higher incidence of fertility assistance and complications of pregnancy, including gestational hypertension and diabetes.12,17,18,21, 22, 23, 24”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
In the citing paper
“In addition, it is recognized that IR plays a major role in the pathophysiology of all of the metabolic diseases, cardiovascular disease, some neurodegenerative diseases, and selected cancers [22,157].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [157]
In the citing paper
“Women with PCOS experience increased cardiometabolic risk—including the metabolic syndrome, hypertension, insulin resistance, obesity and dyslipidemia—predisposing them to increased risk for diabetes and cardiovascular disease (CVD).2,10,17, 18, 19, 20”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
In the citing paper
“The diagnosis of PCOS included the ICD-9 and ICD-10 codes, and these have been validated and used in previous epidemiologic studies.6,10,17,27,32,55, 56, 57”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [17]
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults
Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., Coresh, J., & Brancati, F. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908359 · Cited by 1,544
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 4×
“001 1 3966 (21) 208 (19) 3758 (22) 5324 (10) 62 (6) 5262 (10) 2 4106 (22) 90 (8) 4016 (23) 6494 (12) 24 (2) 6470 (12) $3 31 (3) 31 (3) 1382 (8) 2392 (4) 13 (1) 2379 (4)”
BackgroundInfluentialWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939
Research works printed but not linked: 1
- 2012, Polycystic ovary syndrome: an update, Aust Fam Physician, 41, 752
Cited by
Items 201–223 of 223
Marchesan, L. B. (2024) · Lume (Universidade Federal do Rio Grande do Sul)
Decoding genetic associations of female reproductive health traits
Pujol‐Gualdo, N. (2024) · DSpace repository (University of Tartu)
Polycystic ovary syndrome – burden and adverse outcomes
Subramanian, A. (2023) · University of Birmingham Institutional Research Archive (University of Birmingham)
Vpliv sindroma policističnih jajčnikov na pojav diabetesa tipa dva
Zdovc, N. (2023) · Repository of the University of Ljubljana (University of Ljubljana)
Failoc-Piscoya, R. A., & Padilla-Mariluz, D. A. (2025) · Revista Experiencia en Medicina del Hospital Regional Lambayeque · doi:10.37065/rem.v11i2.816
Wüest, A. (2020) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-020-00147-y
Mudrikatin, S., & Ahmadi, E. A. (2024) · Inovasi Kesehatan Global · doi:10.62383/ikg.v1i4.967
Anabolic androgenic steroid use and risk of diabetes mellitus in males
Esmann, F. V. L., Heerfordt, I. M., Windfeld‐Mathiasen, J., Horwitz, A., Dalhoff, K., Andersen, J. T., Middelboe, M., & Horwitz, H. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70283
Sex hormones, type 2 diabetes mellitus, and chronic kidney disease
Lau Hui Ying, L. (2023) · doi:10.5282/edoc.32804
Marchesan, L. B., Ramos, R. B., & Spritzer, P. M. (2021) · doi:10.3389/fendo.2021.759835.s002
Naderpoor, N., Ng, N. Y. H., Chew, A., Khomami, M. B., Moran, L., Mousa, A., Tay, C. T., Teede, H. J., & Ronald, C. W. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7511414
Günay, E. (2024) · eArsiv - Adu (Adnan Menderes University)
Polycystic Ovary Syndrome : Mechanisms of Development and Novel Treatments
Aflatounian, A. (2021) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/22475
PCOS and Cardiometabolic Health over the Reproductive Years
Kakoly, N. S. (2019) · Figshare · doi:10.26180/5d194e6c84ad5
Polycystic ovary syndrome and pregnancy complications : Focus on hyperandrogenism and comorbidity
Valdimarsdottir, R. (2024) · Uppsala University Publications (Uppsala University)
Batool, A., Marrium, S. K.-T.-S., Islam, S., Kiyani, A., Hanjra, H., & Azam, H. (2021) · Journal of Health, Medicine and Nursing · doi:10.7176/jhmn/90-13
Tỷ lệ bất thường dung nạp đường ở phụ nữ hiếm muộn người Việt Nam có hội chứng buồng trứng đa nang
Nguyễn, T. N., Ho, V. N. A., Pham, T. D., Nguyen, M. H. N., Lý, Đ. L., Hồ, M. T., & Vuong, L. N. (2023) · Tạp chí Phụ sản · doi:10.46755/vjog.2022.2.1362
Pandey, M., & Kejriwal, G. (2026) · International Journal of Clinical Obstetrics and Gynaecology · doi:10.33545/gynae.2026.v10.i3w.2562
Korrapati, A. (2023) · International Journal of Academic Research & Development · doi:10.70381/23951737.v9.n2.2023.7
Torres, R. (2018) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Hancke, K. (2024) · Springer eBooks · doi:10.1007/978-3-662-58895-6_27
Elcano Sarasibar, L. (2019) · Communities in ADDI (University of the Basque Country)
From PCOS to PMOS: Metabolic Implications for Diabetes Care and Education Specialists
Burroughs, B. T., & Zheng, A. (2026) · ADCES in Practice · doi:10.1177/2633559x261473614
Metadata
- Authors
- Rubin, K. H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M.
- Affiliations
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- Corresponding author
- Glintborg, Dorte
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-08-29
- Volume
- 102
- Issue
- 10
- Pages
- 3848-3857
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2751209738
- Cited by
- 195
- References
- 44
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 18 · 2023: 28 · 2022: 26 · 2021: 30 · 2020: 31 · 2019: 18 · 2018: 15 · 2017: 1
- FWCI
- 20.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, type 2 diabetes, diabetes risk factors, insulin resistance, body mass index, HbA1c, fasting blood glucose, HOMA-IR, triglycerides, parity, age at diabetes diagnosis, premenopausal women
- MeSH terms
- Adolescent, Adult, Child, Denmark, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Middle Aged, Polycystic Ovary Syndrome, Registries, Risk Factors, Case-Control Studies, Disease Progression, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.